Order Article Reprints

Collomb B, Dubromel A, Caffin AG, Herledan C, Larbre V, Baudouin A, Cerutti A, Couturier L, Maire M, Karlin L, et al. Assessment of Patient Reported Outcomes (PROs) in Outpatients Taking Oral Anticancer Drugs Included in the Real-Life Oncoral Program. Cancers. 2022; 14(3):660. https://doi.org/10.3390/cancers14030660

Collomb, Bastien, Amélie Dubromel, Anne Gaëlle Caffin, Chloé Herledan, Virginie Larbre, Amandine Baudouin, Ariane Cerutti, Laurence Couturier, Magali Maire, Lionel Karlin, and et al. 2022. "Assessment of Patient Reported Outcomes (PROs) in Outpatients Taking Oral Anticancer Drugs Included in the Real-Life Oncoral Program" Cancers 14, no. 3: 660. https://doi.org/10.3390/cancers14030660

Collomb, B., Dubromel, A., Caffin, A. G., Herledan, C., Larbre, V., Baudouin, A., Cerutti, A., Couturier, L., Maire, M., Karlin, L., Maucort-Boulch, D., Huot, L., Dalle, S., Bachy, E., Ghesquieres, H., Salles, G., Couraud, S., You, B., Freyer, G., ... Rioufol, C. (2022). Assessment of Patient Reported Outcomes (PROs) in Outpatients Taking Oral Anticancer Drugs Included in the Real-Life Oncoral Program. Cancers, 14(3), 660. https://doi.org/10.3390/cancers14030660